Skip to content

Form 4 filed by Pershing Edward

Pershing Edward filed this Form 4 on PROVECTUS BIOPHARMACEUTICALS, INC. with 2 transaction rows and 0 holding rows, accepted by EDGAR 2026-10-24 00:34:56 UTC.

Accession
0001493152-26-048321
Filed
2026-10-23
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

Issuer and reporting owners

Issuer: PROVECTUS BIOPHARMACEUTICALS, INC. (CIK 315545)

Rows

SecurityDateCodeSharesPriceOwned afterOwnership
8% Unsecured Convertible Promissory Note derivative2026-10-23M exercised-$0D
Series D-1 Convertible Preferred Stock derivative2026-10-23M exercised+7,599$03,006,133D